BlueCrest Capital Management Ltd cut its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 65.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,593 shares of the company’s stock after selling 37,707 shares during the period. BlueCrest Capital Management Ltd’s holdings in Express Scripts were worth $1,462,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. SeaCrest Wealth Management LLC purchased a new position in Express Scripts during the fourth quarter worth about $105,000. Aevitas Wealth Management Inc. purchased a new position in Express Scripts during the fourth quarter worth about $128,000. Financial Gravity Companies Inc. acquired a new stake in shares of Express Scripts during the fourth quarter valued at about $142,000. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts during the third quarter valued at about $120,000. Finally, Monroe Bank & Trust MI increased its position in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the last quarter. 89.08% of the stock is currently owned by institutional investors.
In related news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the completion of the transaction, the vice president now owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. Insiders sold 21,896 shares of company stock valued at $1,617,903 in the last 90 days. Company insiders own 0.68% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.07. The firm had revenue of $25.38 billion during the quarter, compared to analysts’ expectations of $25.07 billion. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.88 earnings per share. research analysts expect that Express Scripts Holding will post 9.35 EPS for the current fiscal year.
Express Scripts declared that its Board of Directors has initiated a share repurchase program on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s leadership believes its shares are undervalued.
ESRX has been the subject of a number of recent analyst reports. Deutsche Bank initiated coverage on shares of Express Scripts in a research report on Monday, December 4th. They set a “buy” rating and a $75.00 price target for the company. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, December 4th. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research report on Monday, December 4th. Sanford C. Bernstein upgraded shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research report on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Thursday, December 14th. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $81.97.
ILLEGAL ACTIVITY WARNING: “BlueCrest Capital Management Ltd Has $1.46 Million Holdings in Express Scripts Holding (ESRX)” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/03/13/bluecrest-capital-management-ltd-has-1-46-million-holdings-in-express-scripts-holding-esrx.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.